Can psychedelic compounds play a part in drug dependence therapy?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25561484.
- Also identified by DOI 10.1192/bjp.bp.114.148031.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
After a 40-year hiatus there is now a revisiting of psychedelic drug therapy throughout psychiatry, with studies examining the drugs psilocybin, ketamine, ibogaine and ayahuasca in the treatment of drug dependence. Limitations to these therapies are both clinical and legal, but the possibility of improving outcomes for patients with substance dependency imposes an obligation to research this area.
Medical subject headings
- Hallucinogens
- Substance-Related Disorders